The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Lrrk2 and Lewy body disease
Abstract
Objective: The Lrrk2 kinase domain G2019S substitution is the most common genetic basis of familial and sporadic parkinsonism. Patients harboring the G2019S substitution usually present with clinical Parkinson's disease. Methods: Herein, we report that the most common neuropathology of G2019S‐associated Parkinson's disease is Lewy body disease. Results: Lrrk2 G2019S was observed in approximately 2% (n = 8) of our Parkinson's disease/Lewy body disease cases (n = 405). The mutation was also found in one control subject and one Alzheimer's disease patient, reflecting reduced penetrance. Interpretation: Therapeutic strategies targeted at modulating Lrrk2 kinase activity may be important to treat patients with genetically defined familial or typical sporadic Parkinson's disease. Ann Neurol 2006;59:388–393
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Self-citationStages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Self-citationα-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Influence of interhemispheric interactions on motor function in chronic stroke
Murase, N., Duque, J., Mazzocchio, R., & Cohen, L. G. (2004) · Annals of Neurology · doi:10.1002/ana.10848 · Cited by 1,472
Enhanced genome annotation using structural profiles in the program 3D-PSSM 1 1Edited by J. Thornton
Kelley, L. A., MacCallum, R. M., & Sternberg, M. J. E. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3741 · Cited by 1,468
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228
Multiple system atrophy: A review of 203 pathologically proven cases
Wenning, G. K., Tison, F., ben Shlomo, Y., Daniel, S. E., & Quinn, N. P. (1997) · Movement Disorders · doi:10.1002/mds.870120203 · Cited by 803
A common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17830-1 · Cited by 774
McKeith, I. G. (2004) · Europe PMC (PubMed Central) · Cited by 756
Hamilton, R. L. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00269.x · Cited by 754
Chen, L., & Feany, M. B. (2005) · Nature Neuroscience · doi:10.1038/nn1443 · Cited by 618
McKeith, I., Mintzer, J., Aarsland, D., Burn, D., Chiu, H., Cohen-Mansfield, J., Dickson, D., Dubois, B., Duda, J. E., Feldman, H., et al. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00619-7 · Cited by 618
Self-citation(2004) · doi:10.1002/ana.10846 · Cited by 614
Kachergus, J., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 541
Self-citationA frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
Di Fonzo, A., Rohé, C. F., Ferreira, J., Chien, H. F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17829-5 · Cited by 531
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
Nichols, W. C., Pankratz, N., Hernandez, D., Paisán-Ruíz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17828-3 · Cited by 457
Van Boven, R. W., & Johnson, K. O. (1994) · Neurology · doi:10.1212/wnl.44.12.2361 · Cited by 419
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology
Wszolek, Z. K., Pfeiffer, R. F., Tsuboi, Y., Uitti, R. J., McComb, R. D., Stoessl, A. J., Strongosky, A. J., Zimprich, A., Müller-Myhsok, B., Farrer, M. J., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000125015.06989.db · Cited by 266
Self-citationSensory loss in stroke patients: Effective training of tactile and proprioceptive discrimination
Carey, L. M., Matyas, T. A., & Oke, L. E. (1993) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/0003-9993(93)90158-7 · Cited by 262
Lewy body cortical involvement may not always predict dementia in Parkinson's disease
Colosimo, C. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.852 · Cited by 200
Clinical features of LRRK2‐associated Parkinson's disease in central Norway
Aasly, J. O., Toft, M., Fernandez‐Mata, I., Kachergus, J., Hulihan, M., White, L. R., & Farrer, M. (2005) · Annals of Neurology · doi:10.1002/ana.20456 · Cited by 191
Self-citationInterhemispheric Transfer of Plasticity in the Cerebral Cortex
Calford, M. B., & Tweedale, R. (1990) · Science · doi:10.1126/science.2389146 · Cited by 188
A psychophysical study of the mechanisms of sensory recovery following nerve injury in humans
Van Boven, R. W., & Johnson, K. O. (1994) · Brain · doi:10.1093/brain/117.1.149 · Cited by 165
Enhanced tactile spatial acuity and cortical processing during acute hand deafferentation
Werhahn, K. J., Mortensen, J., Boven, R. W. V., Zeuner, K. E., & Cohen, L. G. (2002) · Nature Neuroscience · doi:10.1038/nn917 · Cited by 155
LRRK2 mutations in Parkinson disease
Farrer, M. J., Stone, J., Mata, I. F., Lincoln, S. J., Kachergus, J. M., Hulihan, M., Strain, K. J., & Maraganore, D. M. (2005) · Neurology · doi:10.1212/01.wnl.0000169023.51764.b0 · Cited by 153
Self-citationInfluence of somatosensory input on motor function in patients with chronic stroke
Flöel, A., Nagorsen, U., Werhahn, K. J., Ravindran, S., Birbaumer, N., Knecht, S., & Cohen, L. G. (2004) · Annals of Neurology · doi:10.1002/ana.20170 · Cited by 145
Mixed-Lineage Kinases: A Target for the Prevention of Neurodegeneration
Wang, L. H., Besirli, C. G., & Johnson, E. M. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121840 · Cited by 144
Pure autonomic failure in association with human α-synucleinopathy
Arai, K., Kato, N., Kashiwado, K., & Hattori, T. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01623-2 · Cited by 108
Silva, R. M., Kuan, C.-Y., RAKIC, P. T., & Burke, R. E. (2005) · Movement Disorders · doi:10.1002/mds.20390 · Cited by 103
LRRK2 R1441G in Spanish patients with Parkinson's disease
Mata, I. F., Taylor, J. P., Kachergus, J. M., Hulihan, M., Huerta, C., Lahoz, C., Estrada, M. B., Guisasola, L. M., Salvador, C., Ribacoba, R., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.033 · Cited by 98
Self-citationWszołek, Z. K., Vieregge, P., Uitti, R. J., Gasser, T., Yasuhara, O., McGeer, P. L., Berry, K., Calne, D. B., Vingerhoets, F. J. G., Klein, C., et al. (1997) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(97)00013-8 · Cited by 82
Escaping Parkinson's disease: A neurologically healthy octogenarian with the LRRK2 G2019S mutation
Kay, D. M., Kramer, P., Higgins, D. S., Zabetian, C. P., & Payami, H. (2005) · Movement Disorders · doi:10.1002/mds.20618 · Cited by 76
Cited by
Genetics of Parkinson's Disease
Klein, C., & Westenberger, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008888 · Cited by 1,358
Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190
Genetic Animal Models of Parkinson's Disease
Dawson, T. M., Ko, H. S., & Dawson, V. L. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.034 · Cited by 823
Parkinson’s disease: genetics and pathogenesis
Shulman, J. M., De Jager, P. L., & Feany, M. B. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130242 · Cited by 801
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., Kee, K., Schüle, B., Dolmetsch, R. E., Langston, W., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.013 · Cited by 745
Metadata
- Authors
- Ross, O. A., Toft, M., Whittle, A. J., Johnson, J. L., Papapetropoulos, S., Mash, D. C., Litvan, I., Gordon, M. F., Wszolek, Z. K., Farrer, M. J., & Dickson, D. W.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2006-01-25
- Volume
- 59
- Issue
- 2
- Pages
- 388-393
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2082214922
- Cited by
- 268
- References
- 33
- FWCI
- 18.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.